-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
CompilationTom Lee
A few days ago, the US Food and Drug Administration (FDA) approved Paige Prostate, an auxiliary software developed by Paige.
Paige.
Paige Prostate software can identify the areas most likely to carry cancer on the prostate biopsy image and mark them for further manual inspection and confirmation by trained professionals
The US FDA's decision to approve the software this time was mainly based on the review of clinical research data.
The results of the study found that with the assistance of Paige Prostate software, pathologists can increase the cancer detection rate of pathological slide images of prostate cancer patients by an average of 7.
The US FDA pointed out that PaigeProstate software is compatible with the slide images digitized by the scanner, and pathologists can use the slide image viewer to visualize the digitized slide images
At the end of 2020, Paige also raised $100 million in venture capital to help the company develop software engineering and commercial teams
Reference source:
1.
2.